Heterogeneity: CSF profile predicts response to interferons

A forum to discuss research on the origins of MS and its development.

Heterogeneity: CSF profile predicts response to interferons

Postby frodo » Wed Jul 04, 2018 3:58 am

In a small study patients were clustered into 6 distinct subsets by baseline cytokine profiles of CSF.

Two subsets were associated with patients who responded poorly to therapy. Two other subsets showed a significant reduction in relapse rates and no worsening of disability.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747480/

Results:

A total of 157 patients were included in the study and clustered into 6 distinct subsets by baseline cytokine profiles. These subsets differed significantly in their clinical and biological response to IFN-β therapy. Two subsets were associated with patients who responded poorly to therapy. Two other subsets, associated with a good response to therapy, showed a significant reduction in relapse rates and no worsening of disability. Each subset also had differential changes in cytokine levels after 3 months of IFN-β

The heterogeneous nature of RRMS was notably described previously where subgroups of patients with RRMS were identified with differences in immunopathologic patterns in lesions. Our data from serum cytokines provide more evidence for immunologically distinct subgroups of MS and suggest these subgroups can stratify treatment response.
User avatar
frodo
Family Elder
 
Posts: 1149
Joined: Wed Dec 02, 2009 3:00 pm

Advertisement

Return to MS Etiology and Pathogenesis

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service